|
Sodium in PDB 7jyc: Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor NarlaprevirEnzymatic activity of Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Narlaprevir
All present enzymatic activity of Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Narlaprevir:
3.4.22.69; Protein crystallography data
The structure of Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Narlaprevir, PDB code: 7jyc
was solved by
B.Andi,
D.Kumaran,
D.F.Kreitler,
A.S.Soares,
W.Shi,
J.Jakoncic,
M.R.Fuchs,
J.Keereetaweep,
J.Shanklin,
S.Mcsweeney,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Sodium Binding Sites:
The binding sites of Sodium atom in the Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Narlaprevir
(pdb code 7jyc). This binding sites where shown within
5.0 Angstroms radius around Sodium atom.
In total only one binding site of Sodium was determined in the Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Narlaprevir, PDB code: 7jyc: Sodium binding site 1 out of 1 in 7jycGo back to Sodium Binding Sites List in 7jyc
Sodium binding site 1 out
of 1 in the Crystal Structure of Sars-Cov-2 Main Protease (3CLPRO/Mpro) in Complex with Covalent Inhibitor Narlaprevir
Mono view Stereo pair view
Reference:
B.Andi,
D.Kumaran,
D.F.Kreitler,
A.S.Soares,
W.Shi,
J.Jakoncic,
M.R.Fuchs,
J.Keereetaweep,
J.Shanklin,
S.Mcsweeney.
Hepatitis C Virus NSP3/NSP4A Inhibitors As Promising Lead Compounds For the Design of New Covalent Inhibitors For Sars-Cov-2 3CLPRO/Mpro Protease To Be Published.
Page generated: Tue Dec 15 18:07:17 2020
|
Last articlesZn in 8WB0Zn in 8WAX Zn in 8WAU Zn in 8WAZ Zn in 8WAY Zn in 8WAV Zn in 8WAW Zn in 8WAT Zn in 8W7M Zn in 8WD3 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |